Impact of Fixed-Duration Oral Targeted Therapies on the Economic Burden of Chronic Lymphocytic Leukemia in Canada

Background: Continuous oral targeted therapies (OTT) represent a major economic burden on the Canadian healthcare system, due to their high cost and administration until disease progression/toxicity. The recent introduction of venetoclax-based fixed-duration combination therapies has the potential t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lachaine, Jean, Guinan, Kimberly, Aw, Andrew, Banerji, Versha, Fleury, Isabelle, Owen, Carolyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217487/
https://www.ncbi.nlm.nih.gov/pubmed/37232797
http://dx.doi.org/10.3390/curroncol30050339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217487/
https://www.ncbi.nlm.nih.gov/pubmed/37232797
http://dx.doi.org/10.3390/curroncol30050339

Ejemplares similares